Want to join the conversation?
$BSX General Update: Boston Scientific Corporation announces that Bronchial Thermoplasty delivered by the Alair System has received support from the American College of Allergy, Asthma and Immunology. BT is an outpatient procedure proven to reduce asthma attacks in adult patients with severe asthma.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.